Introduction
Hematopoietic stem cells (HSC) are responsible for life-long maintenance of hematopoiesis.
They self-renew extensively, give rise to all the major lineages of the peripheral blood and, when infused into a conditioned recipient, have the remarkable ability to home to marrow and replenish the hematopoietic system following its ablation by irradiation or chemotherapy. As such, they are heavily exploited clinically to treat hematologic disease via HSC transplantation.
Dissecting the pathways that regulate HSC survival post-transplantation could greatly benefit efforts in the clinic to improve transplant outcomes in patients. Dimethyl-prostaglandin E2 can enhance the engraftment of CD34+ cord blood in NOD/SCID mice and is currently being explored as a potential clinical regimen 1 . Prostaglandin E2 was first implicated as a novel regulator of HSC homeostasis in a chemical screen in zebrafish 2 . Other studies have shown that CD26-inhibition, para-thyroid hormone pre-treatment, and modulation of Wnt signaling in CD34+ cord blood all show potential to improve HSC function during and post-transplantation [3] [4] [5] [6] .
Molecular regulators of HSC, such as Nurr1, Irgm1, Sox17, Prdm16, and Lkb1, have been identified by examining differential gene expression between quiescent and activated HSC, fetal liver and adult bone marrow HSC, and long-term repopulating HSC [7] [8] [9] [10] [11] . Several functional screens have also identified putative regulators of HSC repopulating ability 12, 13 . In a fresh effort to identify novel HSC molecular regulators, we recently profiled the global gene expression patterns of HSC throughout their ontogeny 14 . Subsequent analysis of this dataset identified putative transcriptional regulators of HSC at each stage of their development 14 . Focusing on genes implicated by this work as potential novel transcriptional regulators of the onset of definitive HSC identity, we have created and employed a lentiviral library of shRNAs to functionally identify genes whose knock-down in murine HSPC perturbs repopulating potential (data not shown). Via this work, we have identified the Nuclear Factor I (Nfi) gene family member, Nfix, as a novel regulator of HSPC repopulating potential and survival.
Nfi genes function as both positive and negative transcriptional regulators of cellular gene expression. Nfi family members (Nfia, Nfib, Nfic, and Nfix) are defined by their unique DNA- [15] [16] [17] [18] [19] . Nfi gene-deficient mice show both overlapping and distinct phenotypes, including underdevelopment of the corpus callosum, postnatal failure to thrive, defects in postnatal tooth root development (Nfic), and impaired lung development (Nfib). Nfix was recently shown to function as a critical regulator of the embryonic to fetal myogenic switch and has also been implicated in the biology of neural progenitors of the embryonic hippocampus 20, 21 .
Although Nfia has been shown to regulate the erythrocytic/granulocytic lineage switch via regulation of miRNA-223 and direct binding to the β-globin and G-CSFR genes, the Nfi gene family has never been linked previously to HSPC biology 22 
Cell culture
293T cells were cultured in Dulbecco`s minimal essential medium (DMEM) with 10% fetal calf serum. HSPC were cultured in SFEM media (StemCell Technologies, Vancouver, British Columbia, Canada) with 10 ng/mL rmScf, 20 ng/mL rmTpo, 20 ng/mL rmIgf-2 (Peprotech, Rocky Hill, NJ), 10 ng/mL rhFGF-1 (R&D Systems, Minneapolis, MN) and 10 mg/mL heparin (Sigma, St Louis, MO).
Lentiviral vector preparation
Vesicular stomatitis virus glycoprotein (VSV-G)-pseudotyped lentivirus was prepared using a four plasmid system (Transfer vector-, Gag/Pol-, Rev/Tat-, and VSV-G envelope plasmid) by cotransfection of 293T cells using TransIT 293 (Mirus, Madison, WI). Viral supernatants were cleared 48 hours post-transfection.
Cell fractionation
Bone marrow was harvested from femurs, tibias and pelvic bones of 6-10 week-old male mice by crushing. c-Kit+ cells were enriched magnetically using anti-c-Kit microbeads (Miltenyi Biotec, Carlsbad, CA). Cells were then stained with fluorescently conjugated antibodies for lineage markers (B220, CD3, CD8, CD19, Gr-1 and TER119), Sca-1, and c-Kit and sorted on a FACSAria III (BD Biosciences, San Diego, CA). 4',6-diamidino-2-phenylindole (DAPI) (Sigma, St Louis, MO) was used to exclude dead cells.
Lentiviral transduction
Non-tissue culture treated 96-well plates were coated with Retronectin (TaKaRA Bio USA, Madison, WI) according to the manufacturer's instructions. Lentiviral particles corresponding to a multiplicity of infection of 25 were spin loaded onto the plates for 1 hour at 1000G and room 
Bone marrow transplantation
8-10 week old recipient mice were lethally irradiated with 11 Gy of ionizing radiation administered in two doses of 5.5 Gy. Twenty-four hours post-transduction, 5000 "Test" LSK cells were washed with PBS and transplanted along with 5000 CD45.1+ "Competitor" LSK cells into each recipient via intravenous tail vein injection.
Cellular analysis
Peripheral blood was collected from the retro-orbital plexus in heparinized capillary tubes and bone marrow from transplant recipients was harvested by crushing. Red blood cells and bone marrow was lysed in Red blood cell lysis buffer (Sigma, St Louis, MO). Cells were stained for surface markers followed by flow cytometry analysis using a BD LSRFortessa (BD Biosciences, San Diego, CA) and data analysis using FlowJo software (Tree Star, Ashland, OR). For cell cycle analysis, cells were fixated with Cytofix/Cytoperm kit (BD Biosciences, San Diego, CA) after staining of surface antigens, followed by staining for Ki-67 and DAPI. Staining of apoptotic cells was proceeded by staining of surface proteins with fluorescently labeled antibodies, followed by labeling with Annexin V-FITC (BD Biosciences, San Diego, CA) and DAPI.
Colony forming assay
Cells were plated in M3434 methylcellulose (StemCell Technologies, Vancouver, British Columbia, Canada). Colonies were scored 10 days after plating.
Microarray analysis
Total RNA was isolated from 15,000 LSK cells cultured for seven days after transduction with either control or Nfix-specific shRNA using the Qiagen RNeasy Micro Kit (Qiagen, Santa Clarita, CA). RNA was amplified using the NuGEN Ovation Pico WTA V2 system and then labeled with the NuGEN Encore Biotin Module (NuGen, San Carlos, CA). Labeled targets were hybridized on the HT MG-430 PM plate array and processed using the GeneTitan system (Affymetrix, Santa Clara, CA). Array data were quantile normalized and rma summarized in 
Quantitative real-time PCR analysis
Total RNA was isolated from 70,000 sorted LSK cells using the Qiagen RNeasy Micro Kit (Qiagen, Santa Clarita, CA). RNA was reverse transcribed using the High Capacity cDNA Reverse Transcription Kit with RNase Inhibitor (Invitrogen, Carlsbad, CA). Quantitative realtime PCR was carried out by an ABI StepOnePlus thermal cycler (Applied Biosystems, Foster City, CA) using SYBR Green. Differences in cDNA input were compensated by normalizing against Tbp expression levels and changes in gene expression were calculated using the ΔΔCt method. Primer sequences are provided in Supplemental Table 3 .
Statistical Analysis
Statistical significance was assessed using two-sided Student's t tests performed with GraphPad Prism 4.03 software (GraphPad, San Diego, CA). P-values were considered statistically significant when P < 0.05 (*), P < 0.01(**) or P < 0.001(***). 
Results

Nfix is expressed by hematopoietic stem and progenitor cells
To identify novel regulators of HSPC, we previously acquired the global gene expression profiles of HSPC isolated from different hematopoietic tissues throughout mouse development 14 . These data revealed that Nfix was highly expressed by definitive adult whole bone marrow (WBM) and fetal liver HSC relative to HSPC present in yolk sac, placenta and aorta-gonadsmesonephros (AGM) mid-gestation ( Figure 1A ). Nfia and Nfic were also expressed, but only by WBM HSC ( Figure 1A 
Nfix is required for the persistence of HSPC ex vivo
To functionally assess a role for Nfix in HSPC, we used shRNAs to disrupt Nfix gene expression. In total, these data reveal that loss of Nfix is detrimental to the short-and long term repopulating potential of HSPC. Figure 7A ). However, a significantly higher proportion of Nfixdeficient mCherry+ LSK cells were undergoing apoptosis, relative to controls ( Figure 7B) . Interestingly, the difference in apoptosis was only significant for both Nfix-shRNA #1 and #2 in the hematopoietic compartment enriched for HSPC (Lineage-Sca-1+c-Kit+) ( Figure 7B ). These data suggest that Nfix-deficient HSPC suffer from increased apoptosis and decreased survival, resulting in an inability to persist in the marrow post-transplantation. repopulating capacity 27 . Mecom, one of the products of the Mds1 and Evi1 complex locus, is critical for HSC repopulating activity, potentially by silencing Cdkn1c, which codes for the Cdk inhibitor p57Kip 28 . The TPO receptor c-Mpl is required for HSPC activity during bone marrow transplantation 29, 30 and steady-state hematopoiesis 31, 32 . Thus, the defect in repopulating activity of HSPC lacking Nfix is likely caused by additive and/or synergistic effects following the decreased expression of these genes. Although further work is required to tease out which of these pathways are directly targeted by Nfix to promote HSPC survival post-transplant, the Mpl/Tpo regulatory axis is a prime candidate given that Mpl expression responds to both a decrease and increase in Nfix levels, in contrast to the other molecular candidates (data not shown).
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In sum, our data reveal that Nfix is required for the survival of HSPC during stress
hematopoiesis. Nfix appears to be upstream, likely both directly and indirectly, of multiple molecular pathways that in concert regulate the delicate balance that occurs between survival and cell death during hematopoietic repopulation following irradiation-induced ablation. Cells
lacking Nfix are at a survival disadvantage in this setting and thus fail to contribute robustly to hematopoietic repopulation. Exploring the downstream effects seen after loss of Nfix might not only increase our understanding of the biology of hematopoietic repopulation but also generate knowledge that could improve clinical bone marrow transplantation protocols. 1 6 expertise in cell sorting and flow cytometry. We thank Richard Gronostajski for Nfix fl/fl mice.
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